Chiu, Connie G <br/><br/>
HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.  [electronic resource] 

 -  Annals of surgery  Jun 2010 
 - 1107-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-1140 
<br/><br/><label>Standard No.: </label>10.1097/SLA.0b013e3181dbb77e  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Breast Neoplasms--metabolism<br/>ErbB Receptors--metabolism<br/>Female<br/>Humans<br/>Middle Aged<br/>Prognosis<br/>Receptor, ErbB-2--metabolism<br/>Receptor, ErbB-3--metabolism<br/>Receptor, ErbB-4<br/>Survival Rate<br/>Tissue Array Analysis